Cilostazol Catalog No.:M9487-2 PubMed PMID: 25649658

PubMed PMID: 25649658

AG14361 suppresses breast cancer cells with IC50s of 17 μM and 25 μM for 92 J-wt-BRCA1 and 92 J-sh-BRCA1 cells

K562 cells) treatment inhibits MAPK/ERK/JNK downstream signaling and diminishes Jak2/Stat3/Akt expression

H2O/c1-15-27-38(10

Molecular Weight: 170

Cilostazol Catalog No.:M9487-2 PubMed PMID: 25649658Cilostazol is a quinolinone derivative medication used in the alleviation of the symptom of claudication in individuals with peripheral vascular disease. Cilostazol is a phosphodiesterase inhibitor with therapeutic focus on cyclic adenosine monophosphate (cAMP). It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation. It is